NOAEL Studies
Cosmetic Ingredient
2,6-Dihydroxyethylaminotoluene NOAEL Studies
INCI: 2,6-DIHYDROXYETHYLAMINOTOLUENE
CAS: 149330-25-6
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 100 | mg/kg bw/day | rat | oral | 90 day | Subchronic | SCCS; Hruby, R. 90-day toxicity study with “WSI-111” in rats. ÖsterreichischesForschungszentrum Seibersdorf, Seibersdor f, Austria, internal study code: SON7. Archive code at Henkel KGaA, Düsseldorf, Report No. R 9601546 |
SCCNFP Opinion 4 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCNFP Opinion | NOAEL | =100 | mg/kg bw/day | - | dermal | Sub-chronic | repeated dose toxicity | Ref. : 5 2, p.7 |
| SCCNFP Opinion | NOAEL | =100 | mg/kg | rat | oral | 13 weeks | dermal absorption | p.18 |
| SCCNFP Opinion | NOAEL | =100 | mg/kg bw | rat | oral | 13 weeks | sensitisation | p.18 |
| SCCNFP Opinion | NOAEL | =200 | mg/kg bw | - | - | - | NOAEL study | Ref. : 14, p.9 |
SCCS Opinion 6 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =100 | mg/kg bw/d | - | - | Chronic | genotoxicity | p.15 |
| SCCS Opinion | NOAEL | =200 | mg/kg bw | rat | oral | - | NOAEL study | p.21 |
| SCCS Opinion | NOAEL | =0 | mg/kg bw | rat | oral | 90 day | reproductive toxicity | p.24 |
| SCCS Opinion | NOAEL | =200 | mg/kg bw/d | rat | oral | 90 day | reproductive toxicity | p.24 |
| SCCS Opinion | NOAEL | =0.036 | mg/kg bw/d | rat | oral | 90-day | dermal absorption | p.26 |
| SCCS Opinion | NOAEL | =84 | mg/kg bw/d | rat | oral | 90-day | dermal absorption | p.26 |
Regulatory source 15 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 100 | mg/kg | rat | oral | 13 weeks | - | p.18 |
| Regulatory source | - | 200 | mg/kg bw | - | - | - | - | p.9 |
| Regulatory source | dermal absorption | =100 | mg/kg | rat | oral | 13 weeks | dermal absorption | p.18 |
| Regulatory source | repeated dose toxicity | 100 | mg/kg bw/day | - | dermal | Sub-chronic | repeated dose toxicity | p.7 |
| Regulatory source | sensitisation | 100 | mg/kg bw | rat | oral | 13 weeks | sensitisation | p.18 |
| Regulatory source | sensitisation | 200 | mg/kg bw | rat | oral | 90 day | sensitisation | p.18 |
| Regulatory source | - | 200 | mg/kg bw | rat | oral | - | - | p.21 |
| Regulatory source | dermal absorption | =0.036 | mg/kg bw/d | rat | oral | 90-day | dermal absorption | p.26 |
| Regulatory source | dermal absorption | =100 | mg/kg bw/d | rat | oral | 90-day | dermal absorption | p.26 |
| Regulatory source | dermal absorption | =84 | mg/kg bw/d | rat | oral | 90-day | dermal absorption | p.26 |
| Regulatory source | genotoxicity | 100 | mg/kg bw/d | - | - | Chronic | genotoxicity | p.15 |
| Regulatory source | reproductive toxicity | 0 | mg/kg bw | rat | oral | 90 day | reproductive toxicity | p.24 |
| Regulatory source | reproductive toxicity | 200 | mg/kg bw/d | rat | oral | 90 day | reproductive toxicity | p.24 |
| Regulatory source | reproductive toxicity | 0 | mg/kg bw | rat | oral | 90-day | reproductive toxicity | p.27 |
| Regulatory source | reproductive toxicity | 200 | mg/kg bw/d | rat | oral | 90-day | reproductive toxicity | p.27 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | I50F7J73SU | UNII | - | - | - | chemical | - |